Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay

  • Read more about Clinical Evaluation of the VitaSIRO Solo™ Respiratory Assay

PDO Based Drug Sensitive Test in R/M HNSCC

  • Read more about PDO Based Drug Sensitive Test in R/M HNSCC

PDO Based Drug Sensitive Test in R/M SGC

  • Read more about PDO Based Drug Sensitive Test in R/M SGC

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

  • Read more about A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, National Multicenter Observational and Retrospective From June 2023 to April 2024

  • Read more about Evaluation of Direct Antiviral Treatments Against SARS-CoV-2 in Immunocompromised Patients With Covid-19. A G2i Study, National Multicenter Observational and Retrospective From June 2023 to April 2024

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

  • Read more about Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

  • Read more about A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults

Improving Health Status in COVID-19 Long-Hauler

  • Read more about Improving Health Status in COVID-19 Long-Hauler

A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

  • Read more about A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Exciva GmbH

By jpalfreyman on Thu, 11/07/2024 - 09:50
  • Read more about Exciva GmbH

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 78
  • Page 79
  • Page 80
  • Page 81
  • Current page 82
  • Page 83
  • Page 84
  • Page 85
  • Page 86
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA